Ursodeoxycholic acid treatment lowers the serum level of antibodies against pyruvate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis

Journal of Molecular Medicine

Volumn 74, Issue 5, 1996, Pages 269-274

  Kisand, K E ^a   Karvonen, A L ^b   Vuoristo, M ^c   Farkkila M ^c   Lehtola, J ^e   Inkovaara, J ^b   Kisand, K V ^a   Miettinen, T ^c   Krohn, K ^d   Uibo, R ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e UNIVERSITY OF OULU   (Finland)

Author keywords

Autoantibodies; Colchicine; Primary biliary cirrhosis; Pyruvate dehydrogenase; Ursodeoxycholic acid

Indexed keywords

AUTOANTIBODY; COLCHICINE; IMMUNOGLOBULIN G; PLACEBO; PYRUVATE DEHYDROGENASE; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIMARY BILIARY CIRRHOSIS; RANDOMIZED CONTROLLED TRIAL;

EID: 0029946273     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050028     Document Type: Article

References (26)

1. Kaplan MM (1993) New strategies needed for treatment of primary biliary cirrhosis. Gastroenterology 104:651-653
2. Leuschner U, Fischer H, Kurtz W, Güldütuna S, Hübner K, Hellstern A, Gatzen M, Leuschner M (1989) Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 97:1268-1274
3. Turner IB, Myszor M, Mitchison HC, Bennett MK, Burt AD, James OFW (1994) A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis. J Gastroenterol Hepatol 9:162-168
4. Poupon RE, Balkau B, Eschwege E, Poupon R, UDCA-PBC Study Group (1991) A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 324:1548-1554
5. Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, Wiesner RH, Anderson ML, Lange SM, Lesage G, Rossi SS, Hofman AF (1994) Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 106:1284-1290
6. Kaplan MM, Alling DW, Zimmerman HJ, Wolfe HJ, Sepersky RA, Hirsch GS, Elta GH, Glick KA, Eagen KA (1986) A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med 315:1448-1454
7. Bodenheimer H, Schaffner F, Pezzullo J (1988) Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology 95:124-129
8. Calmus Y, Gane P, Rouger P, Poupon R (1990) Hepatic expression of class I and II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 11:12-15
9. Gershwin ME, Mackay IR, Sturgess A, Coppel RL (1987) Identification and specificity of a cDNA encoding the 70kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138:3525-3531
10. Yeaman SJ, Fussey SPM, Danner DJ, James OFW, Mutimer DJ, Bassendine MF (1988) Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet I:11067-11070
11. Yoshida T, Bonkovsky H, Ansari A, Danner D (1990) Antibodies against mitochondrial dehydrogenase complexes in primary biliary cirrhosis. Gastroenterology 99:187-194
12. Begley JP, Barry RE, Denton RM, Stansbie D (1991) Inhibition of the activity of the 2-oxoacid dehydrogenase complexes by sera from patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 3:365-369
13. Kisand K, Kisand K, Salupere V, Uibo R (1994) Enzyme-linked immunosorbent assays for the determination of IgG, IgA and IgM autoantibodies to pyruvate dehydrogenase in primary biliary cirrhosis. Int J Clin Lab Res 24:98-101
14. Yeaman SJ (1986) The mammalian 2-oxoacid dehydrogenases: a complex family. Trends Biochem Sci 11:293-296
15. Vuoristo M, Färkkilä M, Karvonen A-L, Leino R, Lehtola J, Mäkinen J, Mattila J, Friman C, Seppälä K, Tuominen J, Miettinen TA (1995) A placebo controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology 108:1470-1478
16. Laemlli UK, Favre M. Maturation of the head of bacteriophage T4 (1973) J Mol Biol 80:575-599
17. Teoh KL, Rowley MJ, Zafirakis H, Dickson ER, Wiesner RH, Gershwin ME, Mackay IR (1994) Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis: applications of a semiautomated assay. Hepatology 20:1220-1224
18. Teoh K-L, Mackay IR, Rowley MJ, Fussey SPM (1994) Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry. Hepatology 19:1029-1033
19. Gilburd B, Ziporen L, Zharhary D, Blank M, Zurgil N, Scheinberg MA, Guedes LH, Gershwin ME, Shoenfeld Y (1994) Antimitochondrial (pyruvate dehydrogenase) antibodies in leprosy. J Clin Immunol 14:14-19
20. Klein R, Wiebel M, Engelhart S, Berg PA (1993) Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Clin Exp Immunol 92:308-316
21. Krams SM, Van de Water J, Coppel RL, Esquivel C, Roberts J, Ansari A, Gershwin ME (1990) Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis. Hepatology 12:306-313
22. Van de Water J, Ansari A, Surh CD, Coppel R, Roche T, Bonkovsky H, Kaplan M, Gershwin ME (1991) Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 146:89-94
23. Van de Water J, Turchany J, Leung PS, Lake J, Munoz S, Surh CD, Coppel R, Ansari A, Nakanuma Y, Gershwin ME (1993) Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest 91:2653-2664
24. Gershwin ME, Mackay IR (1991) Primary biliary cirrhosis: paradigma or paradox for autoimmunity. Gastroenterology 100:822-833
25. Stiehl A, Rudolph G, Raedsch R, Möller B, Hopf U, Lotterer E, Bircher J, Folsch U, Klaus J, Endete R, Senn M (1990) Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology 12:492-497
26. Calmus Y, Weill B, Ozier Y, Chereau C, Houssin D, Poupon R. (1992) Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse. Gastroenterology 103:617-621